Prior Stephen David - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 4, 2025, Prior Stephen David's relationship to AN2 Therapeutics, Inc. (ANTX) is Officer (Chief Strategy Officer), and currently has 65,548 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ANTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Prior Stephen David - Insider Non-Derivative Transactions of ANTX Common Stock

Prior Stephen David - Insider Non-Derivative Transactions at ANTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 5, 2025	Sell -- (Common Stock)	765	1.14	65548
Feb 27, 2025	Acquisition -- (Common Stock)	28000	0	61313
Jan 4, 2025	Sell -- (Common Stock)	2029	1.34	33313
Nov 5, 2024	Acquisition -- (Common Stock)	10125	0	35342